MedTrace Logo

Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer

NCT04977596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2021-07-27

No results posted yet for this study

Summary

1. Imaging findings (including CT and MRI images) of both well-differentiated G3 PNET and poorly differentiated PNET were studied;
2. The CT imaging findings of G3 stage PNET and pancreatic cancer were compared to establish a Logistic regression diagnostic model, and the survival analysis of the two was compared.
3. Cox regression was used to study the risk factors for survival prognosis of well-differentiated and poorly differentiated PNET based on CT image features

Conditions

  • Neuroendocrine Tumor of Pancreas
  • Carcinoma, Pancreatic
  • CT

Interventions

OTHER

No intervention

Retrospective study without intervention

Sponsors & Collaborators

  • Zhejiang University

    collaborator OTHER

  • The First Affiliated Hospital of the Fourth Military Medical University

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Risheng Yu · Second Affiliated Hospital of Zhejiang University School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2019-01-01
Completion
2019-06-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04977596 on ClinicalTrials.gov